Cancer-Associated Cachexia and Underlying Biological Mechanisms
- 1 August 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 26 (1), 435-461
- https://doi.org/10.1146/annurev.nutr.26.061505.111151
Abstract
▪ Abstract Cancer metastases (spread to distant organs from the primary tumor site) signify systemic, progressive, and essentially incurable malignant disease. Anorexia and wasting develop continuously throughout the course of incurable cancer. Overall, in Westernized countries nearly exactly half of current cancer diagnoses end in cure and the other half end in death; thus, cancer-associated cachexia has a high prevalence. The pathophysiology of cancer-associated cachexia has two principal components: a failure of food intake and a systemic hypermetabolism/hypercatabolism syndrome. The superimposed metabolic changes result in a rate of depletion of physiological reserves of energy and protein that is greater than would be expected based on the prevailing level of food intake. These features indicate a need for nutritional support, metabolic management, and a clear appreciation of the context of life-limiting illness.Keywords
This publication has 148 references indexed in Scilit:
- Normalization of hypothalamic serotonin (5-HT1B) receptor and NPY in cancer anorexia after tumor resection: An immunocytochemical studyNeuroscience Letters, 2005
- Effects of omega-3 fatty acid supplementation on tumor-bearing ratsJournal of the American College of Surgeons, 2004
- Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trialJournal of Pain and Symptom Management, 2004
- Aggressive pharmacological treatment for reversing malignant bowel obstructionJournal of Pain and Symptom Management, 2004
- Cachexia in cancer patientsNature Reviews Cancer, 2002
- Efficacy of Haloperidol in the Treatment of Nausea and Vomiting in the Palliative Patient: A Systematic ReviewJournal of Pain and Symptom Management, 2001
- Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexiaJournal of Pain and Symptom Management, 1997
- Taste and Smell in DiseaseNew England Journal of Medicine, 1983
- Taste and Smell in DiseaseNew England Journal of Medicine, 1983
- Stimulation of Muscle Protein Degradation and Prostaglandin E2Release by Leukocytic Pyrogen (Interleukin-1)New England Journal of Medicine, 1983